上海百心安生物技術股份有限公司（“公司”）于2025年12月4日发布2025年11月的股份变动月报表。报告显示，截至本报告期末，公司注册股本总额为人民币243,417,100元，其中包括在香港联交所上市的H股235,703,422股，以及非上市外资股7,713,678股，面值均为每股人民币1元。报告期内，公司没有新增发行，也未发生购回、注销或库藏股变动，公司股本总体保持稳定。
公司在月报中指出，其未开展任何股份期权、股权激励计划或购回与注销活动。至2025年11月30日，公司已发行股份总数继续维持在243,417,100股，其中H股占235,703,422股，非上市外资股占7,713,678股。
公司强调其遵守香港联交所《上市规则》及相关法律规定。公告由执行董事兼联席公司秘书王云磬呈交。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.